AB Soft ii manual

Models: ii

1 36
Download 36 pages 35.93 Kb
Page 15
Image 15

28.Liang SY, Yates P, Edwards H, Tsay SL. Factors influencing opioid-taking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psychooncology, 3/2008.

29.Lin CC. Comparison of the effects of perceived self-efficacy on coping with chronic cancer pain and coping with chronic low back pain. Clin J Pain 14(4): 303-310, 12/1998.

30.Lin CC, Wang P, Lai YL, Lin CL, Tsai SL, Chen TT. Identifying attitudinal barriers to family management of cancer pain in palliative care in Taiwan. Palliat Med 14(6): 463-470, 11/2000.

31.Lin CC. Barriers to the analgesic management of cancer pain: a comparison of attitudes of Taiwanese patients and their family caregivers. Pain 88(1): 7-14, 10/2000.

32.Lin CC. Congruity of cancer pain perceptions between Taiwanese patients and family caregivers: relationship to patients' concerns about reporting pain and using analgesics. J Pain Symptom Manage 21(1): 18-26, 1/2001.

33.Lin CC, Lai YL, Ward SE. Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. J Pain Symptom Manage 25(1): 29-37, 1/2003.

34.Lin JT, Mathew P. Cancer pain management in prisons: a survey of primary care practitioners and inmates. J Pain Symptom Manage 29(5): 466-473, 5/2005.

35.Long HJ, III, Monk BJ, Huang HQ, Grendys EC, Jr., McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study. Gynecol Oncol 100(3): 537-543, 3/2006.

36.Lundorff L, Peuckmann V, Sjogren P. Pain management of opioid-treated cancer patients in hospital settings in Denmark. Acta Anaesthesiol Scand 52(1): 137-142, 1/2008.

37.Maltoni M, Scarpi E, Modonesi C, Passardi A, Calpona S, Turriziani A, Speranza R, Tassinari D, Magnani P, Saccani D, Montanari L, Roudnas B, Amadori D, Fabbri L, Nanni O, Raulli

P, Poggi B, Fochessati F, Giannunzio D, Barbagallo ML, Minnotti V, Betti M, Giordani S, Piazza E, Scapaticci R, Ferrario

S. A validation study of the WHO analgesic ladder: a two-step

vs three-step strategy. Support Care Cancer 13(11): 888-894, 11/2005.

38.McMillan SC, Tittle M, Hagan S, Laughlin J. Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nurs 23(5): 327-336, 10/2000.

39.McMillan SC, Tofthagen C, Morgan MA. Relationships among pain, sleep disturbances, and depressive symptoms in outpatients from a comprehensive cancer center. Oncol Nurs Forum 35(4): 603-611, 7/2008.

40.McQuellon RP, Thaler HT, Cella D, Moore DH. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 101(2): 296-304, 5/2006.

41.McQuellon RP, Danhauer SC, Russell GB, Shen P, Fenstermaker J, Stewart JH, Levine EA. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 14(3): 1105-1113, 3/2007.

42.Meghani SH, Keane A. Preference for analgesic treatment for cancer pain among African Americans. J Pain Symptom Manage 34(2): 136-147, 8/2007.

43.Monk BJ, Huang HQ, Cella D, Long HJ, III. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 23(21):

4617-4625, 7/2005.

44.Mystakidou K, Parpa E, Tsilika E, Mavromati A, Smyrniotis V, Georgaki S, Vlahos L. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J Pain 4(6): 298-306, 8/2003.

45.Mystakidou K, Tsilika E, Parpa E, Kouloulias V, Kouvaris I, Georgaki S, Vlahos L. Long-term cancer pain management in

25

26

Page 15
Image 15
AB Soft ii manual